CD22-directed autologous CAR-T cells

CD22-targeted CAR-T cell therapy · University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD22-directed autologous CAR-T cells, covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: CD22 Redirected Autologous T Cells for ALL [Phase 1]